Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | AR | P10275 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5110942 | 0.91 | FFAR1 (0.37) | FFAR1ARGAAMAPTLMNA | |
| SCHEMBL5117669 | 0.91 | FFAR1 (0.37) | FFAR1ARGAAMAPTLMNA | |
| SCHEMBL5110522 | 0.90 | THRB (0.40) | FFAR1ARTHRB | |
| SCHEMBL5118715 | 0.87 | MME (0.39) | FFAR1ARMRGPRX4PPARG | |
| SCHEMBL4931582 | 0.86 | FFAR1 (0.39) | FFAR1GAAMAPTTACR1MRGPRX4 | |
| SCHEMBL4935426 | 0.86 | FFAR1 (0.39) | FFAR1TACR1MRGPRX4S1PR1SLC7A5 | |
| SCHEMBL4931768 | 0.86 | FFAR1 (0.40) | FFAR1GAAMAPTTACR1MRGPRX4 | |
| SCHEMBL4934384 | 0.86 | FFAR1 (0.37) | FFAR1TACR1MRGPRX4S1PR1HPGD | |
| SCHEMBL4932666 | 0.85 | FFAR1 (0.38) | FFAR1GAAMAPTTACR1MRGPRX4 | |
| SCHEMBL5112161 | 0.84 | ALDH1A1 (0.38) | FFAR1TACR1MRGPRX4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080004251-A1 | Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor | KARO BIO AB (SE) | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004251-A1 | Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor | TSHR, TRHR, THRA | FFAR1 34/4885AR 253/4885GAA 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.